A class action lawsuit has been filed against GlaxoSmithKline in the Superior Court for the State of California County of Los Angeles claiming the company employed false and deceptive marketing tactics when marketing the antidepressant medication Paxil. The lawsuit is entitled Grair v. GlaxoSmithKline, Class Action Case No. BC 288536 and includes anyone who paid a subscription for Paxil in the state of California between the dates of 01/14/99 to 01/01/03. Paxil is a antidepressant medicine that helps treat depression, obsessive-compulsive disorder, generalized anxiety disorder and social anxiety conditions. The class members claim that this antidepressant medication was habit-forming or addicting. GlaxoSmithKline denies all wrong doing in the case but has agreed to a $8,500,000.00 settlement in order to end the lawsuit.
GlaxoSmithKline will provide a full refund of the Out-of-Pocket Expenses of Settlement Class Members who timely submit a valid Proof of Purchase and a sworn statement verifying eligibility. If you do not have a valid Proof of Purchase will provide eighty dollars ($80.00) per claimant but you must submit a sworn statement verifying eligibility. A settlement fairness hearing is scheduled for November 13, 2012 at 9:00 a.m but is subject to change and payments will be made once the “final approval” of the settlement and any appeals are resolved. All claims forms are due by October 10, 2012. If you would like to exclude yourself for the terms of the Grair v. GlaxoSmithKline settlement please write to: Paxil Settlement Administrator, c/o GCG, P.O. Box 9839, Dublin, OH 43017-5739 and include your name, address, telephone number, and signature. If you have a 
lawyer please submit his/her name and contact information. Class members will be represented by Kabateck, Brown, Kellner, LLP, Khorrami, LLP, and Milstein Adelman, LLP at no charge. If you want to be represented by your own lawyer, you may hire one at your own expense. CapaxilClassAction.com includes the claim form, Settlement Agreement and Release and the Order Preliminarily Approving Class Action Settlement. Adobe Reader will be required to view the PDF documents.
